Dosing Mounjaro starts at 2.5 mg weekly for four weeks, then increases to 5 mg
Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
Vitamin B12 Injection FAQ's How quickly will I notice a difference after my B12 injection
Semaglutide and tirzepatide are legal in India with a doctor's prescription
If you have Hashimoto's and are exploring GLP-1 medications for weight management or metabolic benefit, the Precision Peptide Genetic Test can help you and your endocrinologist make a more informed decision about whether compounded GLP-1 therapy (semaglutide or tirzepatide) is appropriate for you, and what monitoring plan is necessary to maintain thyroid stability